Moreover, the presence of comorbidities (especially DM), portal hypertension, multinodular disease (with more than three tumoral masses), AFP levels higher than 300 ng/mL, high TBS, and nodule diameter larger than 6 cm indicate poor overall survival (p = 0.001). Here, AFP is linked to portal hypertension.